Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025npj Digital MedicineOpen Access

A randomised controlled trial of a low-carbohydrate digitally-supported weight loss programme for type 2 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

EMElizabeth MorrisJSJadine ScraggRSRichard Stevens

Discussion

Loading...

Member takes

Overview

Randomised controlled trial shows no meaningful impact on glycaemic control in type 2 diabetes, indicating limitations of digital support.

Key Points

  • Weight loss was greater at 3 months in the intervention group, but not sustained at 12 months.
  • Mean weight loss was 2.6 kg at 3 months, but subsequently decreased to -0.4 kg by 12 months.
  • Randomised controlled trial compared a low-carbohydrate intervention with usual care in 115 individuals.
  • Intervention did not significantly influence glycaemic control or cardiovascular risk factors beyond standard care.

Cite This Study

Morris et al. (2025) studied this question.

synapsesocial.com/papers/6930e8dbea1aef094cca3d23https://doi.org/10.1038/s41746-025-02116-w
View Full Paper
Ask AI
Bookmark
Share